VEGFA and retinopathy of prematurity: VEGF-A165 is a variant of VEGF-A, with pro-angiogenic properties, and its sustained release in phase I ROP was shown to promote vascular regeneration in OIR mice, while reducing venous dilation and arterial tortuosity and preventing severe ROP [46,47].